These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2657246)

  • 1. Immunomodulation with thymopentin: in vitro studies.
    Duchateau J; Bolla K
    Med Oncol Tumor Pharmacother; 1989; 6(1):19-23. PubMed ID: 2657246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation with thymopentin in humans.
    Bolla K; Duchateau J; Delespesse G; Servais G
    Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro influence of thymopentin on proliferative responses and phytohemagglutinin-induced interleukin 2 production in normal human lymphocyte cultures.
    Duchateau J; Servais G; Cooman R; Collet H; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():116-24. PubMed ID: 3898283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production.
    Meroni PL; Barcellini W; Frasca D; Sguotti C; Borghi MO; De Bartolo G; Doria G; Zanussi C
    Clin Immunol Immunopathol; 1987 Feb; 42(2):151-9. PubMed ID: 3542319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination.
    Záruba K; Rastorfer M; Grob PJ; Joller-Jemelka H; Bolla K
    Lancet; 1983 Nov; 2(8361):1245. PubMed ID: 6139582
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stimulation of immunogenesis by neurotensin, pentagastrin and thymopentin and ways of its realization].
    Belokrylov GA; Molchanova IV; Popova OIa
    Biull Eksp Biol Med; 1989 Nov; 108(11):584-7. PubMed ID: 2699257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients.
    Munno I; Pellegrino NM; Fumo G; Barbieri G; Polimeno G; de Filippis V; Jirillo E
    Cytobios; 1987; 52(210-211):167-73. PubMed ID: 3123147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.
    Ochoa EL; Medrano S; de Carlin MC; Dilonardo AM
    Cell Mol Neurobiol; 1988 Sep; 8(3):325-31. PubMed ID: 3066488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of immune response in aged humans through different administration modes of thymopentin.
    Duchateau J; Servais G; Vreyens R; Delespesse G; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():94-101. PubMed ID: 3898299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide.
    Diezel W; Waschke SR; Forner K
    Biomed Biochim Acta; 1984; 43(6):K9-12. PubMed ID: 6435610
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymopoietin to thymopentin: experimental studies.
    Goldstein G; Audhya TK
    Surv Immunol Res; 1985; 4 Suppl 1():1-10. PubMed ID: 2994196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of two new immunomodulators on normal and burn injury neutrophils and macrophages.
    Waymack JP; Miskell P; Gonce SJ; Alexander JW
    J Burn Care Rehabil; 1987; 8(1):9-14. PubMed ID: 3553203
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of TP-5 on the production of C3, PGE2, and TXB2 by macrophages obtained from burned guinea pigs.
    Ogle CK; Ogle JD; Keynton L; Nagy H; Alexander JW
    J Burn Care Rehabil; 1989; 10(2):146-50. PubMed ID: 2651450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for the biological activity of thymopentin analogs.
    Heavner GA; Audhya T; Kroon D; Goldstein G
    Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of two new immunomodulators.
    Waymack JP; Gonce S; Miskell P; Alexander JW
    Arch Surg; 1985 Jan; 120(1):43-8. PubMed ID: 3917663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of thymopentin on antibody response, and monocyte and T cell function in hemodialysis patients who fail to respond to hepatitis B vaccination.
    Dumann H; Meuer SC; Renschin G; Köhler H
    Nephron; 1990; 55(2):136-40. PubMed ID: 2194133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide.
    Laghi Pasini F; Auteri A; Ceccatelli L; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):316-22. PubMed ID: 7018516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide.
    Rentz E; Diezel W; Ehrlich A; Forner K
    Arch Geschwulstforsch; 1984; 54(2):113-8. PubMed ID: 6329122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.